Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger
The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...
Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
The market didn't appreciate Amgen's (NASDAQ: AMGN) latest clinical data update, with the biopharma's shares falling more ...
The Globe and Mail6h
3 Mega-Cap Stocks to Buy Before They're Worth $1 Trillion
Mounjaro's growth trajectory is bolstered by accelerating international sales, positioning it as a cornerstone of Eli Lilly's ...
Futurism on MSN11h
Woman Annoyed When She Gets on Wegovy and It Does Nothing
For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...
The New York Times23h
World News
Prime Minister Justin Trudeau of Canada is the first foreign G7 leader to visit President-elect Donald J. Trump since the election. He is under pressure to persuade Mr. Trump to back down from his ...
ABC News1h
Political News
The president-elect made the announcement on Truth Social on Sunday. ABC News’ MaryAlice Parks discusses President Joe Biden's invitation for President-elect Donald Trump to visit the White ...